ArticlePDF Available

Diffuse pulmonary haemorrhage accompanied by haemothorax as a rare presentation of primary lung angiosarcoma

Authors:

Abstract and Figures

Primary pulmonary angiosarcoma is an extremely rare disease. Chest computed tomography demonstrates solitary or multifocal lesions, sometimes associated with ground-glass opacities or pleural effusion. Diagnosis is based on histological examination that reveals spindle-shaped epithelioid cells with positive staining for endothelial markers (factor VIII, CD 31, CD34, Fli-1, Ulex europaeus agglutinin 1, vimentin). The prognosis is poor and effective treatment is still being researched. This is a report of a 65-year-old patient with a four-month history of haemoptysis, cough, and dyspnoea. The primary radiological findings suggested interstitial lung disease. After one month the clinical presentation evolved into diffuse pulmonary haemorrhage with concomitant haemothorax. The diagnosis of primary lung angiosarcoma was based on histological and immunohistochemical examination of the lung and pleural biopsy obtained by videothoracoscopy.
Content may be subject to copyright.
Kardiochirurgia i Torakochirurgia Polska 2015; 12 (4) 367
Address for correspondence: Katarzyna Modrzewska, MD, III Department of Lung Diseases, Institute of Tuberculosis and Lung Diseases,
26 Płocka St., 01-138 Warsaw, Poland, phone: +48 506 131 729, e-mail: k.modrzewska@hotmail.com
Streszczenie
Pierwotny płucny naczyniakomięsak (angiosarcoma) jest nie-
zwykle rzadką chorobą. Badanie tomograi komputerowej płuc
demonstruje najczęściej pojedyncze guzy lub mnogie guzki,
czasami z towarzyszącymi zmianami o typie matowej szyby lub
płynu opłucnowego. Rozpoznanie ustala się na podstawie oceny
histologicznej, która uwidacznia wrzecionowate komórki epite-
lioidalne wybarwiające się w kierunku markerów śródbłonko-
wych (czynnik VIII, CD 31, CD34, Fli-1, Ulex europaeus agglutinin 1,
vimentina). Rokowanie jest bardzo złe, nadal poszukiwane są
skuteczne metody leczenia. W pracy zaprezentowano przypa-
dek 65-letniej pacjentki z 4-miesięcznym wywiadem krwio-
plucia, kaszlu i duszności. Początkowe badania radiologiczne
sugerowały śródmiąższową chorobę płuc. Po miesiącu obraz
kliniczny ewoluował w kierunku rozsianego krwawienia płuc-
nego z towarzyszącym krwiakiem opłucnej. Rozpoznanie pier-
wotnej płucnej angiosarcomy zostało ustalone na podstawie
oceny histologicznej i immunohistochemicznej bioptatów płuc
i opłucnej pobranych drogą wideotorakoskopii.
Słowa kluczowe: naczyniakomięsak, rozlany krwotok płucny,
krwiak opłucnej.
CASE REPORTS
Abstract
Primary pulmonary angiosarcoma is an extremely rare disease.
Chest computed tomography demonstrates solitary or multifo-
cal lesions, sometimes associated with ground-glass opacities
or pleural eusion. Diagnosis is based on histological exami-
nation that reveals spindle-shaped epithelioid cells with posi-
tive staining for endothelial markers (factor VIII, CD 31, CD34,
Fli-1, Ulex europaeus agglutinin 1, vimentin). The prognosis is
poor and eective treatment is still being researched. This is
a report of a 65-year-old patient with a four-month history of
haemoptysis, cough, and dyspnoea. The primary radiological
ndings suggested interstitial lung disease. After one month the
clinical presentation evolved into diuse pulmonary haemor -
rhage with concomitant haemothorax. The diagnosis of pri-
mary lung angiosarcoma was based on histological and immu-
nohistochemical examination of the lung and pleural biopsy
obtained by videothoracoscopy.
Key words: angiosarcoma, diuse pulmonary haemorrhage,
haemothorax.
Diuse pulmonary haemorrhage accompanied
by haemothorax as a rare presentation of primary lung
angiosarcoma
Katarzyna Modrzewska1, Elżbieta Radzikowska1, Małgorzata Szołkowska2, Karina Oniszh3,
Magdalena Szczęsna4, Kazimierz Roszkowski-Śliż1
1III Department of Lung Diseases, Institute of Tuberculosis and Lung Diseases in Warsaw, Poland
2Department of Pathology, Institute of Tuberculosis and Lung Diseases in Warsaw, Poland
3Department of Radiology, Institute of Tuberculosis and Lung Diseases in Warsaw, Poland
4Department Thoracic Surgery, Institute of Tuberculosis and Lung Diseases in Warsaw, Poland
Kardiochirurgia i Torakochirurgia Polska 2015; 12 (4): 367-371
DOI: 10.5114/kitp.2015.56792
Introduction
Primary pulmonary angiosarcoma (PPA) is a rare neo-
plasm originating from endothelial cells of small vessels of
the lung [1]. The highest incidence of the disease occurs in
the fth and sixth decade of life. Chest computed tomog-
raphy (CT) demonstrates solitary or multifocal lesions occa-
sionally accompanied by ground-glass opacities or pleural
eusion [2-4]. Diuse alveolar haemorrhage with concomi-
tant haemothorax is an extremely rare manifestation of
primary angiosarcoma of the lung. There has been only
one other report published with a similar presentation [5].
The diagnosis is based on histological ndings comple-
mented by immunohistochemical stainings typical for en-
dothelial markers. Due to high malignancy, patients with
angiosarcoma have a low rate of survival. An eective
therapeutic regimen is still being researched. We present
a case of rapid progression of PPA manifested as bilateral
pulmonary opacities and haemothorax.
Kardiochirurgia i Torakochirurgia Polska 2015; 12 (4)368
Diuse pulmonary haemorrhage accompanied by haemothorax as a rare presentation of primary lung angiosarcoma
Case report
A 65-year-old smoking woman presented a four-month
history of haemoptysis, cough, and dyspnoea. The patient’s
medical history was signicant for chronic obstructive pul-
monary disease (COPD), permanent atrial brillation (AF)
under continuous anticoagulation treatment, hypertension,
and diabetes. Due to severe haemoptysis, she reduced the
dose of anticoagulant by 50% without medical consultation.
Chest CT performed one month prior to hospitalisation re-
vealed bilateral interstitial opacities with air bronchogram
and ground-glass attenuations. The radiological ndings
suggested interstitial lung disease, and the patient was
referred to our Department. On admission the general con-
dition of the patient was severe. She presented dyspnoea
in rest and massive haemoptysis. Physical examination
showed obesity (BMI 47.5), tachypnoea (30 per minute),
tachycardia (105 per minute), and oedema of the ankles. On
auscultation, the respiratory sounds over the lower right
lobe were diminished, and crackles over the middle right
lobe and the whole left lung were detected. The patient
had respiratory insuciency (PaO2 – 50 mmHg, PaCO2
33 mmHg, pH 7.48). Laboratory tests revealed an elevated
level of C-reactive protein (26.5 mg/dl), D-dimer (3991 ng/
ml) and anaemia (haemoglobin 9 g/dl, haematocrit 29.7%).
Chest X-ray demonstrated right-sided opacity correspond-
ing to pleural uid, scattered pulmonary lesions, and mod-
erately enlarged hila (Fig. 1). Computed tomography scans
of the chest showed progression of bilateral ground-glass
opacities of dierent shape and size with peripheral pre-
dilection, small nodules (including one peripheral left lung
nodule with slight cavitation), right-sided pleural eusion,
and enlargement of the heart (Fig. 2 and 3). There were no
radiological signs of pulmonary embolism in large branches
of pulmonary arteries, but a suggestion that small vessels
could have been lled with thrombotic material was made.
Echocardiography showed enlargement of the right ventri-
cle and both atria, and elevated pulmonary artery pressure
at 42 mmHg. The values of tumour markers (cancer antigen
CA 15-3, CA 19-9, CA 125, carcinoembryonic antigen), anti-
neutrophil cytoplasmic antibody (ANCA), and anti-nuclear
antibody (ANA) were in normal range. Ultrasonography
of the abdomen did not reveal any pathological masses.
Bronchoscopy revealed a bronchi eld with a signicant
amount of fresh blood without any visible point of origin.
The bacterial and fungal cultures of bronchial washing
were negative. Due to severe dyspnoea, two pleurocente-
ses were performed. The drainage was close to 1000 ml of
bloody uid. The haematocrit of the eusion was 19.8%
and it was higher than 50% of the haematocrit of periph-
eral blood, which met the criteria of true haemothorax.
The cytological examination of bronchial washing and pleu-
ral uid was negative for neoplasmatic cells. On suspicion
of immunologically-induced intra-alveolar haemorrhage,
80 mg of prednisone was administrated. After a brief sta-
bilisation, videothoracoscopic pleural and lung biopsy was
performed. Intra-operative biopsy for frozen section exami-
nation did not reveal any neoplasmatic cells. During the
next two days after the surgery the condition of the patient
was critical and she died a few days after.
Microscopic examination of pleural samples revealed
that the areas of slit spaces were lled with erythrocytes and
surrounded by epithelioid cells. Immunohistochemical re-
actions showed diuse reactivity with anti-CD31 (LC70, Cell
Marque) antibody (Fig. 4) and focal anti-CD34 (QBEnd/10,
Cell Marque) staining. Reactions with cytokeratins (AE1AE3,
Roche) and calretinin (SP65, Roche) were negative. In the
lung specimen, cohesive and ill-dened lesions were found.
On microscopic examination, the lesions were composed
of groups of loosely packed epithelioid cells mixed with -
brin and erythrocytes. Adjacent alveolar spaces were lled
with red blood cells and haemosiderin-laden macrophages
(Fig. 5). A diagnosis of epithelioid angiosarcoma was estab-
lished.
Discussion
Primary epithelioid angiosarcoma of the lung is an ex-
tremely rare disease. Typically, angiosarcomas occur as skin
and subcutaneous tissue neoplasms of the head, neck, and
lower and upper extremities, or involve the heart and ex-
trathoracic organs [3, 4]. Pulmonary manifestation must be
rst of all dierentiated with metastasis from other organs.
There are no typical factors associated with development
of these tumours. Some reports suggest a correlation be-
tween radiotherapy, chemotherapy, past surgical interven-
tions, environmental carcinogens, or chronic tuberculosis
pyothorax [1, 3, 6, 7].
Primary pulmonary angiosarcoma patients complain
of haemoptysis, dyspnoea, cough, weight loss, fatigue,
pleuritic chest pain, and sometimes fever [3, 8]. Our pa-
tient presented most of these symptoms. Nevertheless,
due to nonspecic complaints, continuous anticoagulant
Fig. 1. Chest radiograph shows right-sided opacity corresponding
to pleural uid; diuse pulmonary lesions focally conuent, for-
ming bigger opacities within left lung; hila moderately enlarged
Kardiochirurgia i Torakochirurgia Polska 2015; 12 (4) 369
CASE REPORTS
therapy, history of heart disease, misleading radiological
features, and rapid progression, the diagnosis was made in
a very advanced and metastatic stadium. In the presented
case, the clinical condition was also complicated by mas-
sive right-sided pleural eusion. The haematocrit of the
uid was higher than 50% of the haematocrit of peripheral
blood, which met the criteria of true haemothorax [9].
There are no dierences between PPA and metastatic
angiosarcoma of the lung in radiological manifestation.
In both cases CT demonstrates solitary or multifocal le-
sions, sometimes associated with ground-glass opacities
or pleural eusion. Usually at the time of diagnosis, the
neoplasm presents extensive local and metastatic invasion
[1-4]. The rst lung CT scan of our patient was confusing.
It showed abnormalities suggesting interstitial pneumonia.
There were no signs of typical tumour. Radiological chang-
es evolved with the progression of the disease. Images ob-
tained on admission revealed bilateral pulmonary opacities
with ground-glass attenuations, a small number of nodules,
and pleural eusion. There is only one case reported with
this rare presentation of PPA [5].
The histological examination of epithelioid angiosar-
comas reveals single or multifocal tumours composed of
sheets of atypical epithelioid cells, focal vasoformative
areas, and necrosis. Haematoxylin-eosin stained sections
show irregularly anastomosing vessels, cells with nuclear
atypia, and often a high mitotic count [4, 6]. The diagnosis
needs to be conrmed by immunohistochemical reactions.
Factor VIII, CD 31, CD34, Fli-1, Ulex europaeus agglutinin 1,
and vimentin are typical endothelial markers [4, 7, 8]. The
biopsy specimen of our patient showed positive reaction
for CD 31 and CD 34. The other stains, including cytokeratin
(AE1/AE3) for epithelial and calretinin for mesothelial pro-
liferations, were negative. It is suggested that at least two
markers should be present in order to conrm the endothe-
lial origin [8].
Fig. 2. Computed tomography scan shows a large right pleural eusion
Kardiochirurgia i Torakochirurgia Polska 2015; 12 (4)370
Diuse pulmonary haemorrhage accompanied by haemothorax as a rare presentation of primary lung angiosarcoma
Fig. 3. High-resolution computed tomography (HRCT) scans: multiple ground-glass opacities, predominantly subpleural; some small
nodules bilaterally
Fig. 5. Epithelioid angiosarcoma. Low- and medium-power magni-
cation of a pulmonary lesion composed of epithelioid cells, haemor-
rhages, and brin deposits surrounded by hyperaemic lung pa-
renchyma with aggregations of haemosiderin-laden macrophages
(HE staining, magnication 200×)
Fig. 4. Epithelioid angiosarcoma, pleural lesion. Epithelioid cells
revealed diuse reactivity with anti-CD31 antibody (CD31, magni-
cation 200×)
Kardiochirurgia i Torakochirurgia Polska 2015; 12 (4) 371
CASE REPORTS
Unfortunately, the survival rate in primary pulmonary
manifestation is less than 39 months [8]. There have been
reports summarising poor prognostic factors for angiosar-
comas, such as age (> 70 years), tumour size (> 5 cm), me-
tastases at presentation, grade, and mitotic count, but they
are still under debate [7, 10].
The presented case is a rare manifestation of primary
pulmonary angiosarcoma with diuse pulmonary haemor-
rhage and haemothorax. Non-distinctive clinical and radio-
logical symptoms and a rapidly progressive course make
this type of neoplasm a considerable challenge for clini-
cians. Our case is a reminder of the necessity to include
PPA in dierential diagnosis of diuse alveolar haemor-
rhage and haemothorax.
Disclosure
Authors report no conict of interest.
References
1. Patel AM, Ryu JH. Angiosarcoma in the lung. Chest 1993; 103: 1531-1535.
2. Foran P, Colleran G, Madewell J, O’Sullivan PJ. Imaging of thoracic sarcomas
of the chest wall, pleura and the lung. Semin Ultrasound CT MR 2011; 32:
365-376.
3. Atasoy C, Fitoz S, Yigit H, Atasoy P, Erden I, Akyar S. Radiographic, CT, and
MRI ndings in primary pulmonary angiosarcoma. Clin Imaging 2001; 25:
337-340.
4. Obeso Carillo GA, Garcia Fontan EM, Canizares Carretero MA, Perez Pedrosa A.
Primary pulmonary angiosarcoma, an exceptional neoplasm with a poor
prognosis: reports of two cases and review of the literature. Gen Thorac
Cardiovasc Surg 2013; 61: 643-647.
5. Liu SF, Wu CC, Lai YF, Hsieh MJ. Massive hemoptysis and hemothorax
caused by pleuropulmonary angiosarcoma. Am J Emerg Med 2002; 20: 374-
375.
6. Weissferdt A, Moran CA. Primary vascular tumors of the lungs: a review.
Ann Diagn Pathol 2010; 14: 296-308.
7. Young RJ, Brown NJ, Reed MW, Hughes D, Woll PJ. Angiosarcoma. Lancet
Oncol 2010; 11: 983-991.
8. Wilson R, Galros R, Brown RK, Michael C, Reisman D. Complete radiographic
response of primary pulmonary angiosarcomas following gemcitabine and
taxotere. Lung Cancer 2008; 61: 131-136.
9. Moriya Y, Sugawara T, Arai M, Tsuda Y, Uchida K, Noguchi T, Arai T, Taka-
kashi H. Bilateral massive bloody pleurisy complicated by angiosarcoma.
Intern Med 2007; 46: 125-128.
10. Lindet C, Neuville A, Penel N, Lae M, Michels JJ, Trassard M, Terrier P,
Birtwisle-Peyrottes I, Valo I, Collin F, Chateau MC, Robin YM, Coindre JM.
Localised angiosarcomas: the identication of prognostic factors and anal-
ysis of treatment impact. A retrospective analysis from the French Sarcoma
Group (GSF/GETO). Eur J Cancer 2013; 49: 369-376.
... PEA is a rare type of angiosarcoma, with a structure characterized by single or multifocal tumors composed of sheets of atypical epithelioid cells. The main pathological manifestations of PEA include diffuse patchy distributions of spindle cells, abundant cytoplasm of cancer cells, prominent capillary-like vasoformative elements, hemorrhage pools, papillary growth, prominent nucleoli, marked atypical nuclei and necrosis (7,24). ...
... Angiosarcoma is characterized by high expression levels of vascular endothelial markers, including factor VIII-related antigens, CD31, CD34, FLI-1 and ERG (6)(7)(8)17,24). Factor VIII-related antigen has the highest specificity; however, it has the lowest sensitivity (17). ...
Article
Full-text available
Primary pulmonary epithelioid angiosarcoma is a rare tumor type without any specific clinical and imaging features. Therefore, it is associated with high rates of misdiagnosis. The present study reports the case of a 54-year-old female patient who was admitted after complaining of cough, expectoration and bloody sputum for >5 months in May 2021. The patient reported a previous history of papillary thyroid carcinoma in 2003 and had undergone treatment through surgery, postoperative chemotherapy and iodine131 therapy. Chest computed tomography (CT) was performed in May 2021, which indicated that the disease had progressed rapidly since February 2021. CT-guided lung biopsy and immunohistochemical staining of the tumor indicated positivity for CD31, CD34 and E26 transformation-specific-related gene markers. The tumor was negative for thyroid cancer-associated antibodies; thus, a diagnosis of primary pulmonary epithelioid angiosarcoma was made. The patient died 3 months after the diagnosis. Primary pulmonary epithelioid angiosarcoma is a rare tumor type with high recurrence and metastasis rates. This tumor has no specific clinical symptoms and signs and is thus easily misdiagnosed. Biopsy is essential for diagnosis of the disease, particularly if patients have a tumor history.
Article
Full-text available
Background: Primary angiosarcoma of the lung is a very aggressive rare malignant disease resulting in a severe prognosis (1). This type of cancer represents about 2% of all soft tissue sarcomas and has a high rate of metastasis through the hematogenous route. For the rarity of this malignant vascular tumor it is still challenging to set a diagnosis (1). The diagnostic features that have thus far been considered include primarily clinical and radiological findings. In some cases, immunohistochemical characteristics based on the most common markers used in pathology have been described. The aim of this report is to present two cases of angiosarcoma of the lung in which the aldehyde dehydrogenase (ALDH) marker was analyzed by immunohistochemistry. Methods: We report two cases of angiosarcoma of the lung in patients underwent lung surgery at our Unit. In addition to the standard histopathological analysis for this disease, immunohistochemistry using an ALDH1A1 antibody was performed in both of the cases. For ALDH quantification, a semi-quantitative method based on the positivity of the tumor cells was used: 0 (<5%), 1 (5–25%), 2 (>25–50%), 3 (>50–75%), 4 (>75%). Results: One patient with recurrent lung disease survived, achieving complete remission after chemo- and radiotherapy. The second patient died of recurrent disease within 5 years of diagnosis. ALDH1A1 was evaluated in both of these cases using an immunohistochemistry scoring system based on the positivity for this marker. The scores were consistent with the patients' clinical outcomes, as the lower (score 1) was observed in the patient with the better clinical outcome, while the higher (score 3) was seen in the patient with the worse outcome. Conclusion: Our data suggest that ALDH may be an important clinical marker in angiosarcoma of the lung. Although further studies need to be performed in a larger cohort of patients, we believe that, if the results will be confirmed, ALDH1A1 may be used to stratify patients in terms of prognosis and for targeted therapy.
Article
Full-text available
Background Angiosarcoma involving the lung can represent either primary or metastatic malignancy. Due to the rarity of this condition, knowledge surrounding the natural history and clinical presentation is scarce. The aim of this scoping review is to summarize the existing literature on pulmonary angiosarcoma, particularly as it pertains to the clinical presentation and ancillary tests used for diagnosis in addition to histopathology. Methods We will conduct a systematic search using Ovid MEDLINE and EMBASE electronic databases. Two investigators will independently screen identified titles and abstracts to select articles reporting on pulmonary angiosarcoma. The data will be summarized in a narrative fashion and organized according to aspects of epidemiology, risk factors, clinical presentation, diagnostic methods, and treatment. Discussion Scoping reviews are increasingly used to synthesize the evidence on a particular topic, to identify gaps in the literature, and to determine if future systematic reviews are feasible. In order to improve the care of patients with angiosarcoma, earlier recognition and diagnosis is required. This review will be valuable for highlighting the range of clinical presentations and the role of imaging and other diagnostic tools in the diagnosis of metastatic and primary pulmonary angiosarcoma. Systematic review registration PROSPERO registration: CRD42017059052 Electronic supplementary material The online version of this article (doi:10.1186/s13643-017-0531-6) contains supplementary material, which is available to authorized users.
Article
We report a case of angiosarcoma complicated by bilateral massive bloody pleurisy (hematocrit of 7.2%) in an 83-year-old woman. An autopsy revealed hemorrhagic tumors infiltrating both the diaphragm and serosal surface of the peritoneum. Histological examination confirmed an anastomosing vascular channel pattern of the tumor cells with characteristic immunohistochemical findings for angiosarcoma, such as positive staining for vimentin, CD31, CD34, D2-40, and factor VIII-related antigen. The tumor was thought to have originated from a small vessel on the serosal surface of the duodenum. We also reviewed cases of hemothorax associated with angiosarcoma, which suggested that primary or metastatic pleural angiosarcoma should be considered a cause of spontaneous hemothorax, especially in patients with bilateral and/or intractable hemothorax.
Article
Cutaneous angiosarcoma without edema of the scalp and face mostly occurs in elderly patients. It has a poor prognosis because of metastasis even at an early stage. We studied the clinical aspects, including treatment, of 9 cases of angiosarcoma diagnosed at our university hospital between April 1991 and March 2003. The male to female ratio was 8:1 at the time of diagnosis, the patients ranged in age from 60 to 77 years (mean 68.7). The tumors were mostly located on the scalp. At the first visit, all patients had reddish-violet macules and 8 had maculonodules. All were treated with interleukin-2 and wide electron beam irradiation; only 2 cases underwent surgery. At the time of this report, 3 patients were still alive. Of the 18 cases who have been treated at our university hospital since 1980, the average survival time of 17 cases was 23.6 months (range 1 to 120 months). One patient was excluded from analysis because treatment was only recently initiated. The cumulative 5-year survival rate was 14.1%. The cumulative 5-year survival rate of the 8 patients since 1980 who were treated with interleukin-2 injections and wide electron beam irradiation without surgery was 18.8%. This is similar to reports of those treated with surgery at other institutions. Accordingly, we conclude that surgical treatment for this type of angiosarcoma is not needed.
Article
Primary pulmonary angiosarcoma is a rare type of malignant vascular tumour characterised by proliferation of tumour cells with endothelial features. Up to date, only sixteen cases have been reported in English Literature. Treatment modalities vary from none to surgery, chemotherapeutic regimens, radiotherapy or immunotherapy, but none of them have been shown to be effective. Unfortunately, these tumours are usually very aggressive and overall mortality is very high. We present two cases of patients with a diagnosis of primary pulmonary angiosarcoma, the largest case series ever described, and a review of the scientific literature.
Article
Background: Angiosarcomas represent less than 2% of all adult soft tissue sarcomas. Prognostic factors and the role of (neo-) adjuvant treatments in the management of localised angiosarcomas require further investigation. Methods: We have conducted a retrospective multicenter study (June 1980 to October 2009) of 107 patients with localised angiosarcomas. All of the cases were centrally reviewed by a certified pathologist. Univariate and multivariate analyses were conducted to identify independent poor prognostic factors (PF). Overall survival (OS) and Local Recurrence-Free Survival (LRFS) were estimated using the Kaplan-Meier method. The effect of treatments was explored using the Cox model after adjusting for the PF. Results: The median age was 71 years. 22.4% and 62.6% developed an angiosarcoma in pre-existing lymphoedema and within irradiated tissue respectively. The median OS, LRFS and Disease Recurrence-Free Survival (DRFS) were 38.8, 27 and 36.1 months, respectively. In multivariate analysis, the following parameters influenced the OS: lymphoedema (Hazard ratio (HR)=2.0) and size >5cm (HR=1.5). After adjustment to these PF, R0 margins was the only treatment parameter that improving the OS (HR=0.2). In the multivariate analysis, the LRFS was influenced by an age >70 (HR=1.8) and pre-existing lymphoedema (HR=2.0). After adjustment for these PF, R0 margins (HR=0.5) and adjuvant radiotherapy (HR=0.3) improved the LRFS. Conclusions: Our results suggest the following points: (i) pre-existing lymphoedema, tumour size and age >70 are probably the major prognostic factors in patients with localised angiosarcomas; (ii) the achievement of R0 margins is probably of major importance for improving the patient outcome and (iii) adjuvant radiotherapy probably decreased the risk of local recurrence.
Article
Primary sarcomas of the thorax are uncommon. The purpose of this review is to describe the radiologic findings of sarcomas affecting the thorax, in particular the chest wall, pleura, and lungs. Most primary sarcomas affecting the thorax arise in the chest wall, and the most common sarcomas of the chest wall are chondrosarcoma, osteosarcoma, Ewing's sarcoma/primitive neuroectodermal tumor, malignant fibrous histiocytoma, and fibrosarcoma. Primary pleural and pulmonary sarcomas are rare. Although histologic analysis is almost always required for accurate diagnosis, imaging is important for staging of these tumors, and several of these tumors have distinctive radiologic features, allowing the radiologist to narrow the differential diagnosis.
Article
Unlike their counterparts in other organ systems, primary vascular neoplasms of the lung are rare. Most of these lesions have only been reported as isolated case studies or small series. When dealing with malignant lesions, metastasis from extrapulmonary sites will have to be excluded before a primary location in the lungs can be confirmed. In this review, the clinicopathologic, immunophenotypical, ultrastructural, and molecular biologic characteristics of primary vascular tumors of the lungs are discussed. The tumoral conditions that will be addressed include hemangioma, lymphangioma, epithelioid hemangioendothelioma, angiosarcoma, and Kaposi's sarcoma. Their respective differential diagnoses will also be discussed.
Article
Angiosarcomas are rare soft-tissue sarcomas of endothelial cell origin that have a poor prognosis. They can arise anywhere in the body, most commonly presenting as cutaneous disease in elderly white men, involving the head and neck and particularly the scalp. They can be caused by therapeutic radiation or chronic lymphoedema and hence secondary breast angiosarcomas are an important subgroup. Recent work has sought to establish the molecular biology of angiosarcomas and identify specific targets for treatment. Interest is now focused on trials of vascular-targeted drugs, which are showing promise in the control of angiosarcomas. In this review we discuss angiosarcoma and its current management, with a focus on clinical trials investigating the treatment of advanced disease.
Article
Angiosarcoma involving the lung is a rare disorder and its clinical features are not well known. We conducted a retrospective analysis of 15 patients seen at our institution from 1950 to 1990 in an attempt to better characterize the spectrum of clinical and radiographic findings of angiosarcoma in the lung. No documented case of primary angiosarcoma of the lung was seen. The diagnosis of metastatic angiosarcoma to the lung was made antemortem in 12 of 15 cases, either by lung biopsy specimen (5 patients), biopsy evidence of metastatic disease elsewhere with abnormal chest radiograph (4 patients), or a compatible clinical picture in a patient with previously documented angiosarcoma arising in an extrapulmonary site (3 patients). The median age at the time of diagnosis was 45 years with the most common presenting symptom being hemoptysis (7 of 15 patients). Other presenting complaints included weight loss (6 of 15), cough (4 of 15), and chest pain (4 of 15) occurring 6 weeks to 1 year prior to diagnosis. Chest radiographs frequently disclosed multiple pulmonary nodules (11 of 15). Primary origins of the angiosarcoma most commonly included the heart and breast. Metastatic sites other than the lung included the pericardium, liver, spleen, kidney, adrenal gland, bone, and brain. The prognosis is generally poor, with our study population surviving an average of 9 months after diagnosis.
Article
We report a rare instance of primary pulmonary angiosarcoma presenting as a large solitary mass in the left upper lobe with mediastinal invasion. In particular, we emphasize the magnetic resonance (MR) imaging features, which included a markedly heterogeneous pattern consisting of hyperintense areas scattered throughout a background of intermediate signal intensity, rendering the lesion a cauliflower-like appearance especially on T2-weighted images. Being unreported so far in primary pulmonary angiosarcomas, these distinct MR imaging findings may be helpful in the differentiation of these neoplasms from lung cancers.